The following legislative changes will apply from Monday 1st April 2019:
◼ Gabapentin will become a Schedule 3 controlled drug (CD No Register POM), but will be exempt from safe custody regulations
◼ Pregabalin will become a Schedule 3 controlled drug (CD No Register POM), but will be exempt from safe custody regulations

Reclassification of Gabapentin and Pregabalin